Obstetrics and Maternity Research
Our team currently has active research in several areas of Maternity care, as you can see below. If you would like to find out more information about any of these studies and how you can take part, please email midwifery.research@nnuh.nhs.uk.
- PANDA: Understanding the real effects of giving low-dose iron supplements during pregnancy to prevent anaemia and its harmful complications, such as babies being born early – PANDA – Clinical Trials Unit – NHS Blood and Transplant.
- The Rainbow Clinic: The impact of a specialist service for parents who have suffered a stillbirth or neonatal death, helping and supporting them through a subsequent pregnancy – The Rainbow Clinic.
- MiNESS 20-28: Investigating modifiable risk factors for early stillbirth between 20-28 weeks of pregnancy – Research & Innovation (cmft.nhs.uk).
- INGR1D2: INvestigating Genetic Risk for type 1 Diabetes (2): An important study that aims to identify children with genetic markers that put them at increased risk of developing Type 1 diabetes – The INGR1D 2 study.
- EMERALD NGM120: A Phase 2 Clinical Trial of a potential treatment (NGM120) for women with Hyperemesis Gravidarum – https://www.ngmbio.com/pipeline/ngm120/.
- PROTECT: The PROTECT study aims to find out if continuous glucose monitoring (CGM) is more effective than finger-prick testing for pregnant mums with Type 2 diabetes. If we can show that CGM is better for managing glucose levels, the NHS will be able to offer this technology to pregnant mums with Type 2 diabetes in the future – PROTECT study.
- Cleft Collective: Investigating the biological and environmental causes of cleft, the best treatments for cleft and the impact of cleft on those affected and their families – The Cleft Collective.
- SNAP2: A randomised controlled trial of enhanced support and nicotine replacement therapy (NRT) for pregnant women to support them to stop smoking – SNAP-2 – The University of Nottingham.